Palisade Bio (NASDAQ: PALI) revenue
Palisade Bio reported revenue of $0.0m for fiscal 2025; in fiscal 2024 it was $0.0m.
Palisade Bio's best year of the last 9 was fiscal 2023. The biggest drop was in fiscal 2019, −94.1%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $0.0m | — | −$18.1m | — |
| 2024 | $0.0m | −100.0% | −$14.9m | — |
| 2023 | $0.3m | — | −$13.1m | −4,356.7% |
| 2022 | $0.0m | — | −$15.7m | — |
| 2020 | $0.0m | −12.2% | −$9.3m | −68,764.8% |
| 2019 | $0.0m | −94.1% | −$8.6m | −56,071.8% |
| 2018 | $0.3m | 0.0% | −$8.3m | −3,176.7% |
| 2017 | $0.3m | +1,500.4% | −$13.3m | −5,118.1% |
| 2016 | $0.0m | — | −$20.6m | −127,027.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Palisade Bio revenue compared with its sector
By revenue for its latest fiscal year, Palisade Bio ranks 413th of the 422 US health care companies with a page on Celsmar.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 411th | Neurogene | $0.0m | −100.0% |
| 412th | Nkarta | $0.0m | — |
| 413th | Palisade Bio | $0.0m | — |
| 414th | Praxis Precision Medicines | $0.0m | −100.0% |
| 415th | Rocket Pharmaceuticals | $0.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Palisade Bio
- How much revenue did Palisade Bio make in fiscal 2025?
- Palisade Bio reported revenue of $0.0m for fiscal 2025, compared with $0.0m in fiscal 2024.
- What was the best year for revenue at Palisade Bio?
- Of its last 9 fiscal years, fiscal 2023, with $0.3m.
- Where does Palisade Bio rank in its sector by revenue?
- It ranks 413th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Palisade Bio come from?
- From the annual report (Form 10-K) that Palisade Bio files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Palisade Bio files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2020 · 2019 · 2018 · 2017 · 2016. More on Palisade Bio: the Palisade Bio page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.